Digital Health Strategy for Acute Kidney Injury
(UPTAKE-1 Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your healthcare provider.
What data supports the effectiveness of the treatment Risk-guided transition of care intervention delivered through an integrated digital health strategy for Acute Kidney Injury?
Is the digital health strategy for acute kidney injury safe for humans?
How is the digital health strategy for acute kidney injury treatment different from other treatments?
What is the purpose of this trial?
Nearly one in ten people who are hospitalized in Canada develop a complication with sudden loss of kidney function, called acute kidney injury (AKI). AKI may lead to other severe health problems after discharge home, such as kidney failure requiring dialysis treatment, heart failure, heart attacks, stroke, and even premature death. Discharge from hospital to home can be a difficult transition where there are often gaps in identification, communication, care coordination, education, and planning of care for AKI. The study team will co-design and evaluate a tailored post-discharge care plan that is based on the risk of later kidney problems and uses currently available, yet untapped digital innovation to improve the health and experience of people with AKI.This study will be built into Alberta's new Epic Systems based provincial electronic health record (EHR). The plan is to use digital tools in the EHR to identify all people in Alberta hospitals that have had an AKI event and are at increased risk of long-term complications. Half will randomly be assigned to receive a tailored care plan based on their risk at hospital discharge while the other half will receive care as it is currently provided by their healthcare team. The electronic health system will automatically calculate a patient's risk and report this risk in their chart along with recommendations for care. The study team includes patients, healthcare providers, and health system decision makers needed to co-develop the proposed strategy and introduce the changes needed to deliver this intervention. The investigators will study whether this strategy can reduce health problems that may happen after AKI including death, chronic kidney disease (CKD), kidney failure, heart attacks, and stroke. The investigators will also determine if the approach improves patient experience during the transition from hospital to home. This study has the potential to revolutionize how we care for people that leave hospital after having AKI.
Research Team
Neesh Pannu
Principal Investigator
University of Alberta
Matthew James
Principal Investigator
University of Calgary
Tyrone Harrison
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for adults over 18 in Alberta hospitals who've had a sudden loss of kidney function (acute kidney injury or AKI) and are at risk of future health issues. They must be hospitalized where the AHS electronic health record system is used.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a tailored post-discharge care plan based on their risk of long-term complications after AKI
Follow-up
Participants are monitored for safety and effectiveness after discharge, including kidney function and cardiovascular events
Patient Experience Assessment
Patient experience is assessed using a survey administered 3 months post-discharge
Treatment Details
Interventions
- Risk-guided transition of care intervention delivered through an integrated digital health strategy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
University of Calgary
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Alberta Health services
Collaborator